113 related articles for article (PubMed ID: 34517056)
1. Suppression of Th2 cytokines as a potential mechanism for reduced antibody response following PFOA exposure in female B6C3F1 mice.
De Guise S; Levin M
Toxicol Lett; 2021 Oct; 351():155-162. PubMed ID: 34517056
[TBL] [Abstract][Full Text] [Related]
2. Immunotoxicity and allergenic potential induced by topical application of perfluorooctanoic acid (PFOA) in a murine model.
Shane HL; Baur R; Lukomska E; Weatherly L; Anderson SE
Food Chem Toxicol; 2020 Feb; 136():111114. PubMed ID: 31904477
[TBL] [Abstract][Full Text] [Related]
3. Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: Role of PPARα and T- and B-cell targeting.
DeWitt JC; Williams WC; Creech NJ; Luebke RW
J Immunotoxicol; 2016; 13(1):38-45. PubMed ID: 25594567
[TBL] [Abstract][Full Text] [Related]
4. Quantifying the impact of PFOA exposure on B-cell development and antibody production.
Taylor KD; Woodlief TL; Ahmed A; Hu Q; Duncker PC; DeWitt JC
Toxicol Sci; 2023 Jun; 194(1):101-108. PubMed ID: 37162486
[TBL] [Abstract][Full Text] [Related]
5. Immunometabolism-modulation and immunotoxicity evaluation of perfluorooctanoic acid in macrophage.
Tian J; Hong Y; Li Z; Yang Z; Lei B; Liu J; Cai Z
Ecotoxicol Environ Saf; 2021 Jun; 215():112128. PubMed ID: 33773150
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of the immunotoxic potential of perfluorinated compounds (PFCs).
Corsini E; Avogadro A; Galbiati V; dell'Agli M; Marinovich M; Galli CL; Germolec DR
Toxicol Appl Pharmacol; 2011 Jan; 250(2):108-16. PubMed ID: 21075133
[TBL] [Abstract][Full Text] [Related]
7. Perfluorooctanoic acid-induced immunotoxicity via NF-kappa B pathway in zebrafish (Danio rerio) kidney.
Zhang H; Shen L; Fang W; Zhang X; Zhong Y
Fish Shellfish Immunol; 2021 Jun; 113():9-19. PubMed ID: 33727078
[TBL] [Abstract][Full Text] [Related]
8. Perfluorooctanoic acid-induced hepatic toxicity following 21-day oral exposure in mice.
Son HY; Kim SH; Shin HI; Bae HI; Yang JH
Arch Toxicol; 2008 Apr; 82(4):239-46. PubMed ID: 17874065
[TBL] [Abstract][Full Text] [Related]
9. Are developmentally exposed C57BL/6 mice insensitive to suppression of TDAR by PFOA?
Hu Q; Strynar MJ; DeWitt JC
J Immunotoxicol; 2010; 7(4):344-9. PubMed ID: 20954796
[TBL] [Abstract][Full Text] [Related]
10. Type 1 and Type 2 cytokines imbalance in adult male C57BL/6 mice following a 7-day oral exposure to perfluorooctanesulfonate (PFOS).
Zheng L; Dong GH; Zhang YH; Liang ZF; Jin YH; He QC
J Immunotoxicol; 2011; 8(1):30-8. PubMed ID: 21299352
[TBL] [Abstract][Full Text] [Related]
11. The role of interleukin family in perfluorooctanoic acid (PFOA)-induced immunotoxicity.
Zhang H; Fang W; Wang D; Gao N; Ding Y; Chen C
J Hazard Mater; 2014 Sep; 280():552-60. PubMed ID: 25212589
[TBL] [Abstract][Full Text] [Related]
12. Does developmental exposure to perflurooctanoic acid (PFOA) induce immunopathologies commonly observed in neurodevelopmental disorders?
Hu Q; Franklin JN; Bryan I; Morris E; Wood A; DeWitt JC
Neurotoxicology; 2012 Dec; 33(6):1491-1498. PubMed ID: 23137609
[TBL] [Abstract][Full Text] [Related]
13. Association between perfluorooctanoic acid exposure and degranulation of mast cells in allergic inflammation.
Lee JK; Lee S; Baek MC; Lee BH; Lee HS; Kwon TK; Park PH; Shin TY; Khang D; Kim SH
J Appl Toxicol; 2017 May; 37(5):554-562. PubMed ID: 27682001
[TBL] [Abstract][Full Text] [Related]
14. Per- and polyfluoroalkyl substances (PFASs) modify lung surfactant function and pro-inflammatory responses in human bronchial epithelial cells.
Sørli JB; Låg M; Ekeren L; Perez-Gil J; Haug LS; Da Silva E; Matrod MN; Gützkow KB; Lindeman B
Toxicol In Vitro; 2020 Feb; 62():104656. PubMed ID: 31536757
[TBL] [Abstract][Full Text] [Related]
15. A mortality study on male subjects exposed to polyfluoroalkyl acids with high internal dose of perfluorooctanoic acid.
Girardi P; Merler E
Environ Res; 2019 Dec; 179(Pt A):108743. PubMed ID: 31542491
[TBL] [Abstract][Full Text] [Related]
16. Perfluorooctanesulfonate and perfluorooctanoate exacerbate airway inflammation in asthmatic mice and in vitro.
Yang M; Li LY; Qin XD; Ye XY; Yu S; Bao Q; Sun L; Wang ZB; Bloom MS; Jalava P; Hu LW; Yu HY; Zeng XW; Yang BY; Dong GH; Li CW
Sci Total Environ; 2021 Apr; 766():142365. PubMed ID: 33601665
[TBL] [Abstract][Full Text] [Related]
17. High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion.
Qazi MR; Bogdanska J; Butenhoff JL; Nelson BD; DePierre JW; Abedi-Valugerdi M
Toxicology; 2009 Aug; 262(3):207-14. PubMed ID: 19540903
[TBL] [Abstract][Full Text] [Related]
18. Activation of sterol regulatory element-binding proteins in mice exposed to perfluorooctanoic acid for 28 days.
Yan S; Wang J; Dai J
Arch Toxicol; 2015 Sep; 89(9):1569-78. PubMed ID: 25092180
[TBL] [Abstract][Full Text] [Related]
19. High perfluorooctanoic acid exposure induces autophagy blockage and disturbs intracellular vesicle fusion in the liver.
Yan S; Zhang H; Guo X; Wang J; Dai J
Arch Toxicol; 2017 Jan; 91(1):247-258. PubMed ID: 26879310
[TBL] [Abstract][Full Text] [Related]
20. Perfluorooctanoic acid induces mast cell-mediated allergic inflammation by the release of histamine and inflammatory mediators.
Singh TS; Lee S; Kim HH; Choi JK; Kim SH
Toxicol Lett; 2012 Apr; 210(1):64-70. PubMed ID: 22322153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
